StocksDeepDive
Snapshot · Russell 3000 · generated 2026-09-19 21:53 UTC

BMRN — BioMarin Pharmaceutical Inc.

EXPENSIVE (MOS -69.3%) · Quality 53/100

Price
63.94
Intrinsic value
37.77
Margin of safety
-69.3%
Implied growth (reverse DCF)
+6.9%
model assumes +0.0%
Value Score
12.7
Quality
53
Psychology
8.2
Discovery
25.1
price/volume attention only
Moat score
42
erosion: none

Value Score: bottom 6% of Russell 3000 · Quality: bottom 19%

Open the interactive Deep Dive for BMRN →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/BMRN - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is BMRN undervalued?

As of 2026-09-19, BMRN trades at 63.94 against a computed intrinsic value of 37.77 (-69.3% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is BioMarin Pharmaceutical Inc.'s Value Score?

BioMarin Pharmaceutical Inc.'s Value Score is 12.7 as of 2026-09-19 - it combines value, quality, crowd psychology and market attention into one number.